High density lipoprotein causes: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
# Impaired synthesis of apo A-1: [[apo A-I deficiency]], apo A-1/C-3 deficiency, apo A-1 structural variants | # Impaired synthesis of apo A-1: [[apo A-I deficiency]], apo A-1/C-3 deficiency, apo A-1 structural variants | ||
# Increased catabolism: [[familial HDL deficiency]] or [[Tangier disease]] | # Increased catabolism: [[familial HDL deficiency]] or [[Tangier disease]] | ||
# Enzymatic changes: genetic, reduced activity of [[lipoprotein lipase]], [[insulin resistance]] | # Enzymatic changes: genetic, reduced activity of [[lipoprotein lipase]], [[insulin resistance]], elevated liver triglyceride lipase activity, LCAT (lecithin cholesterol acyltransferase) deficiency | ||
* [[Diabetes Mellitus]] | * [[Diabetes Mellitus]] | ||
* Drugs | * Drugs | ||
Revision as of 16:47, 15 April 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
High density lipoprotein causes On the Web |
|
American Roentgen Ray Society Images of High density lipoprotein causes |
|
Risk calculators and risk factors for High density lipoprotein causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Causes
- HDL cholesterol is a positive cardiac risk factor if
- HDL < 35 mg/dL
- Total cholesterol to HDL ratio in > 5.0 (in men)
- Total cholesterol to HDL ratio in > 4.5 (in women)
- Negative cardiac risk factor if HDL > 60 mg/dL
Decreased
- Apolipoprotein deficiency: Hypoalphalipoproteinemia can be of three types.
- Impaired synthesis of apo A-1: apo A-I deficiency, apo A-1/C-3 deficiency, apo A-1 structural variants
- Increased catabolism: familial HDL deficiency or Tangier disease
- Enzymatic changes: genetic, reduced activity of lipoprotein lipase, insulin resistance, elevated liver triglyceride lipase activity, LCAT (lecithin cholesterol acyltransferase) deficiency
- Diabetes Mellitus
- Drugs
- Liver disease
- Menopause
- Obesity
- Puberty in males
- Uremia
- Familial combined hypolipidemia
- Elevated CETP (cholesteryl ester transfer protein) activity: Polymorphism of the gene TaqIB (CETP gene) is known to be associated with variations in the plasma concentrations of CETP. A gene variant called TaqIB1 is associated with a higher CETP concentration and lower HDL-C levels in the plasma. Two other mutations that result in similar findings are A373P and R451Q.
Increased
- Drugs
- Moderate alcohol intake
- Regular aerobic exercise
- Weight loss